pharmaceuticals
pharmaceuticals Articles
Shares of Cynapsus Therapeutics more than doubled on Thursday after it was announced that Sunovion Pharmaceuticals would be acquiring the company.
Published:
Last Updated:
Shares of Array BioPharma saw a handy gain in Tuesdays session following the announcement of mid-stage results from its cardiomyopathy trial.
Published:
Last Updated:
Shares of Rigel Pharmaceuticals skyrocketed early on Tuesday after the company reported incredibly positive results from its late-stage blood platelet clinical trial.
Published:
Last Updated:
Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
Mylan is under fire for price gouging on its EpiPen. There has been some concern that this was a serious mistake by CEO Heather Bresch.
Published:
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what price.
Published:
Last Updated:
On Thursday, a few companies in the biotech and pharmaceutical industries made substantial runs. In this case it was all downward.
Published:
Last Updated:
Although some analysts have become less negative and upgraded to a more neutral view on Valeant Pharmaceuticals, Morgan Stanley's is a true call to buy the stock.
Published:
Last Updated:
On Tuesday, a few biotech companies made substantial runs, either up and down, due to the results of FDA approvals, failed or passed trials and even earnings results.
Published:
Last Updated:
Patheon saw its quiet period come to an end on Monday, and the analyst floodgates opened wide. What stood out so much here was that the analyst ratings seem universally positive.
Published:
Last Updated:
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for each of its large cap pharmaceutical stocks.
Published:
Last Updated:
Shares of Aurinia Pharmaceuticals were halved early in Monday’s session following a mid-stage trial hiccup.
Published:
Last Updated:
Jefferies searches for growth with reasonable valuations and upside potential. This week's picks are no exception to that rule.
Published:
Last Updated:
The biggest bit of marijuana industry news in the week ending August 12 was that the DEA rejected a call to loosen federal restrictions on marijuana.
Published:
Last Updated: